AXDX acceleratediagnostics.com: שווי הפעילות העסקית

Accelerate Diagnostics (AXDX) generates revenue through the sale of automated systems for rapid pathogen identification and antibiotic selection, including the sale of consumables. Optimized logistics routes and the establishment of component reserve funds ensure uninterrupted supplies. This price chart illustrating trading dynamics shows that the Enterprise Value is . The business possesses high crisis resilience and pronounced autumn-winter seasonality due to constant demand for emergency sepsis diagnostics.

This metric combines market capitalization and net debt to determine the total acquisition cost of the business, accounting for all liabilities and liquid assets. The Enterprise Value (EV) trend reflects Accelerate Diagnostics (AXDX) shifting toward reducing its debt load amid the implementation of PhenoTest systems, allowing investors to assess the company's real price while considering the embedded commercialization value.